Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
Tóm tắt
Từ khóa
Tài liệu tham khảo
Huisman, 2011, Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update, Eur J Echocardiogr, 12, 313, 10.1093/ejechocard/jer017
Kern, 2001, Evaluation of the culprit plaque and the physiological significance of coronary atherosclerotic narrowings, Circulation, 103, 3142, 10.1161/01.CIR.103.25.3142
Tardif, 2008, Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial, Atherosclerosis, 197, 480, 10.1016/j.atherosclerosis.2006.11.039
Tardif, 2004, Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions, Circulation, 110, 3372, 10.1161/01.CIR.0000147777.12010.EF
Nissen, 2008, Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial, J Am Med Assoc, 299, 1561, 10.1001/jama.299.13.1561
Hirohata, 2010, Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial, J Am Coll Cardiol, 55, 976, 10.1016/j.jacc.2009.09.062
Fayad, 2012, The time has come for clinical cardiovascular trials with plaque characterization as an endpoint, Eur Heart J, 33, 160, 10.1093/eurheartj/ehr243
Biondi-Zoccai, 2011, Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry, Clin Res Cardiol, 100, 1021, 10.1007/s00392-011-0336-x
Rodriguez-Granillo, 2006, Reproducibility of intravascular ultrasound radiofrequency data analysis: implications for the design of longitudinal studies, Int J Cardiovasc Imaging, 22, 621, 10.1007/s10554-006-9080-0
Yokoyama, 2005, Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study, Am Heart J, 150, 287, 10.1016/j.ahj.2005.03.059
Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, BMJ, 339, b2535, 10.1136/bmj.b2535
Moher, 1999, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses, Lancet, 354, 1896, 10.1016/S0140-6736(99)04149-5
2009
Biondi-Zoccai, 2005, Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: a metaregression, Am Heart J, 149, 504, 10.1016/j.ahj.2004.10.026
Yamada, 2007, Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study, Circ J, 71, 1845, 10.1253/circj.71.1845
Takarada, 2010, The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound, JACC Cardiovasc Interv, 3, 766, 10.1016/j.jcin.2010.05.001
Waseda, 2006, Impact of angiotensin II receptor blockers on the progression and regression of coronary atherosclerosis: an intravascular ultrasound study, Circ J, 70, 1111, 10.1253/circj.70.1111
Wakeyama, 2003, Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial, Circ J, 67, 519, 10.1253/circj.67.519
von Birgelen, 2003, Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound, Circulation, 108, 2757, 10.1161/01.CIR.0000103664.47406.49
Tsuchikane, 1998, Impact of cilostazol on intimal proliferation after directional coronary atherectomy, Am Heart J, 135, 495, 10.1016/S0002-8703(98)70327-8
Toi, 2009, Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin, Circ J, 73, 1466, 10.1253/circj.CJ-08-1051
Tani, 2010, Coronary plaque regression and lifestyle modification in patients treated with pravastatin – assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol, Circ J, 74, 954, 10.1253/circj.CJ-09-0705
Tani, 2009, Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment, Am J Cardiol, 104, 464, 10.1016/j.amjcard.2009.04.009
Tani, 2009, Association of body mass index with coronary plaque regression: 6-month prospective study, J Atheroscler Thromb, 16, 275, 10.5551/jat.E653
Takashima, 2007, Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque, Circ J, 71, 1678, 10.1253/circj.71.1678
Arai, 2010, More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome – sub-analysis of JAPAN-ACS study, J Atheroscler Thromb, 17, 1096, 10.5551/jat.5660
Ballantyne, 2008, Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden, Circulation, 117, 2458, 10.1161/CIRCULATIONAHA.108.773747
Hong, 2010, Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis, Korean J Intern Med, 25, 356, 10.3904/kjim.2010.25.4.356
Iwata, 2011, Association between plasma pigment epithelium-derived factor levels and tissue characteristics of coronary plaque using integrated backscatter intravascular ultrasound, Intern Med, 50, 1889, 10.2169/internalmedicine.50.5460
Jensen, 2004, Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study, Circulation, 110, 265, 10.1161/01.CIR.0000135215.75876.41
Kornowski, 1998, Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients, Am J Cardiol, 81, 1298, 10.1016/S0002-9149(98)00157-X
Kovarnik, 2011, Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration, Circ J, 76, 176, 10.1253/circj.CJ-11-0730
Nakayama, 2010, Pioglitazone induces regression of coronary atherosclerotic plaques in patients with type 2 diabetes mellitus or impaired glucose tolerance: a randomized prospective study using intravascular ultrasound, Int J Cardiol, 138, 157, 10.1016/j.ijcard.2008.08.031
Hong, 2007, Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression inpatients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque, Atherosclerosis, 191, 107, 10.1016/j.atherosclerosis.2006.02.040
Nicholls, 2006, Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano, J Am Coll Cardiol, 47, 992, 10.1016/j.jacc.2005.11.040
Nicholls, 2007, Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis, J Am Med Assoc, 297, 499, 10.1001/jama.297.5.499
Nissen, 2003, Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, J Am Med Assoc, 290, 2292, 10.1001/jama.290.17.2292
Nissen, 2005, Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease, N Engl J Med, 352, 29, 10.1056/NEJMoa042000
Nissen, 2006, Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial, J Am Med Assoc, 295, 1556, 10.1001/jama.295.13.jpc60002
Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.
Ogasawara, 2009, Pioglitazone reduces the necrotic-core component in coronary plaque in association with enhanced plasma adiponectin in patients with type 2 diabetes mellitus, Circ J, 73, 343, 10.1253/circj.CJ-08-0699
Otagiri, 2011, Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome: analysis using integrated backscatter IVUS (ELAN study), Circ J, 75, 633, 10.1253/circj.CJ-10-0600
Takayama, 2009, Effect of rosuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS), Circ J, 73, 2110, 10.1253/circj.CJ-09-0358
Hong, 2009, Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis, JACC Cardiovasc Interv, 2, 679, 10.1016/j.jcin.2009.03.015
Kawasaki, 2005, Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound, J Am Coll Cardiol, 45, 1946, 10.1016/j.jacc.2004.09.081
Clementi, 2009, Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis, J Cardiovasc Med (Hagerstown), 10, 231, 10.2459/JCM.0b013e3283212eb6
Hirayama, 2009, Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy, Circ J, 73, 718, 10.1253/circj.CJ-08-0755
Hirayama, 2011, Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound, Circ J, 75, 1448, 10.1253/circj.CJ-10-1035
Takagi, 1997, Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin, Am J Cardiol, 79, 1673, 10.1016/S0002-9149(97)00221-X
Tardif, 2007, Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial, J Am Med Assoc, 297, 1675, 10.1001/jama.297.15.jpc70004
Kojima, 2011, Azelnidipine and amlodipine anti-coronary atherosclerosis trial in hypertensive patients undergoing coronary intervention by serial volumetric intravascular ultrasound analysis in Juntendo University (ALPS-J), Circ J, 75, 1071, 10.1253/circj.CJ-11-0141
Schartl, 2001, of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease, Circulation, 104, 387, 10.1161/hc2901.093188
Lüscher, 2009, A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study, Eur Heart J, 30, 1590, 10.1093/eurheartj/ehp151
Nicholls, 2011, Effect of two intensive statin regimens on progression of coronary disease, N Engl J Med, 365, 2078, 10.1056/NEJMoa1110874
Nissen, 2006, Effect of ACAT inhibition on the progression of coronary atherosclerosis, N Engl J Med, 354, 1253, 10.1056/NEJMoa054699
Nissen, 2008, obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial, J Am Med Assoc, 299, 1547, 10.1001/jama.299.13.1547
Nissen, 2004, Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial, J Am Med Assoc, 292, 2217, 10.1001/jama.292.18.2217
Nissen, 2007, ILLUSTRATE Investigators. Effect of torcetrapib on the progression of coronary atherosclerosis, N Engl J Med, 356, 1304, 10.1056/NEJMoa070635
Nissen, 2004, Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial, J Am Med Assoc, 291, 1071, 10.1001/jama.291.9.1071
Rodriguez-Granillo, 2007, Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study, Eur Heart J, 28, 2326, 10.1093/eurheartj/ehm255
Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4
Dawber, 1951, Epidemiological approaches to heart disease: the Framingham study, Am J Public Health Nations Health, 41, 279, 10.2105/AJPH.41.3.279
Jousilahti, 1999, Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland, Circulation, 99, 1165, 10.1161/01.CIR.99.9.1165
Wasserman, 2008, Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA), Stroke, 39, 329, 10.1161/STROKEAHA.107.498634
Tonstad, 1996, Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects, Arterioscler Thromb Vasc Biol, 16, 984, 10.1161/01.ATV.16.8.984
Zheng, 2011, The relationship between volumetric plaque components and classical cardiovascular risk factors and the metabolic syndrome a 3-vessel coronary artery virtual histology-intravascular ultrasound analysis, JACC Cardiovasc Interv, 4, 503, 10.1016/j.jcin.2010.12.015
Cliff, 1988, The coronary arteries in cases of cardiac and noncardiac sudden death, Am J Pathol, 132, 319
Detrano, 2008, Coronary calcium as a predictor of coronary events in four racial or ethnic groups, N Engl J Med, 358, 1336, 10.1056/NEJMoa072100
Greenland, 2004, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals, J Am Med Assoc, 291, 210, 10.1001/jama.291.2.210
Nicholls, 2010, Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome, J Am Coll Cardiol, 55, 2399, 10.1016/j.jacc.2010.02.026
von Birgelen, 2003, Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (= or >12 months) follow-up intravascular ultrasound, Circulation, 108, 2757, 10.1161/01.CIR.0000103664.47406.49
Bulbulia, 2011, Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial, Lancet, 378, 2013, 10.1016/S0140-6736(11)61125-2
Nabel, 2012, A tale of coronary artery disease and myocardial infarction, N Engl J Med, 366, 54, 10.1056/NEJMra1112570
Costanzo, 2010, Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials, J Am Coll Cardiol, 56, 2006, 10.1016/j.jacc.2010.05.059
Biondi-Zoccai, 2007, Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: evidence from a meta-regression, Am Heart J, 153, 587, 10.1016/j.ahj.2007.01.007
Morton SC, Adams JL, Suttorp MJ, Shekelle PG. Meta-regression approaches: what, why, when, and how? Technical Reviews, No. 8.